메뉴 건너뛰기




Volumn 84, Issue 2, 2013, Pages 309-314

Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: Influence of technological factors

Author keywords

Biodistribution; Charge; High pressure homogenization; Mean residence time; Nanostructured lipid carriers; Size; Surfactant

Indexed keywords

DRUG CARRIER; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; POLOXAMER; POLYSORBATE 80; TECHNETIUM 99M; UNCLASSIFIED DRUG;

EID: 84878324720     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.01.029     Document Type: Article
Times cited : (56)

References (45)
  • 1
    • 79957789430 scopus 로고    scopus 로고
    • Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs
    • Y.S.R. Krishnaiah Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs J. Bioequiv. Availab. 2 2010 28 36
    • (2010) J. Bioequiv. Availab. , vol.2 , pp. 28-36
    • Krishnaiah, Y.S.R.1
  • 2
    • 41949100244 scopus 로고    scopus 로고
    • Drug nanoparticles: Formulating poorly water-soluble compounds
    • E.M. Merisko-Liversidge, and G.G. Liversidge Drug nanoparticles: formulating poorly water-soluble compounds Toxicol. Pathol. 36 2008 43 48
    • (2008) Toxicol. Pathol. , vol.36 , pp. 43-48
    • Merisko-Liversidge, E.M.1    Liversidge, G.G.2
  • 5
    • 51049092308 scopus 로고    scopus 로고
    • Factors affecting the clearance and biodistribution of polymeric nanoparticles
    • F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515
    • (2008) Mol. Pharm. , vol.5 , pp. 505-515
    • Alexis, F.1    Pridgen, E.2    Molnar, L.K.3    Farokhzad, O.C.4
  • 6
    • 79953035086 scopus 로고    scopus 로고
    • PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
    • S. Acharya, and S.K. Sahoo PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Adv. Drug Deliv. Rev. 63 2011 170 183
    • (2011) Adv. Drug Deliv. Rev. , vol.63 , pp. 170-183
    • Acharya, S.1    Sahoo, S.K.2
  • 7
    • 77953026762 scopus 로고    scopus 로고
    • Superparamagnetic iron oxide-loaded poly (lactic acid)-d-α- tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent
    • C. Prashant, M. Dipak, C.-T. Yang, K.-H. Chuang, D. Jun, and S.-S. Feng Superparamagnetic iron oxide-loaded poly (lactic acid)-d-α-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent Biomaterials 31 2010 5588 5597
    • (2010) Biomaterials , vol.31 , pp. 5588-5597
    • Prashant, C.1    Dipak, M.2    Yang, C.-T.3    Chuang, K.-H.4    Jun, D.5    Feng, S.-S.6
  • 8
    • 34547901070 scopus 로고    scopus 로고
    • Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles
    • A.A. Date, M.D. Joshi, and V.B. Patravale Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 505 521
    • (2007) Adv. Drug Deliv. Rev. , vol.59 , pp. 505-521
    • Date, A.A.1    Joshi, M.D.2    Patravale, V.B.3
  • 9
    • 78650679616 scopus 로고    scopus 로고
    • Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting
    • L.F. Lai, and H.X. Guo Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting Int. J. Pharm. 404 2011 317 323
    • (2011) Int. J. Pharm. , vol.404 , pp. 317-323
    • Lai, L.F.1    Guo, H.X.2
  • 10
    • 49449102923 scopus 로고    scopus 로고
    • The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases
    • Y. Gao, W. Gu, L. Chen, Z. Xu, and Y. Li The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases Biomaterials 29 2008 4129 4136
    • (2008) Biomaterials , vol.29 , pp. 4129-4136
    • Gao, Y.1    Gu, W.2    Chen, L.3    Xu, Z.4    Li, Y.5
  • 13
    • 28844488494 scopus 로고    scopus 로고
    • Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
    • D.E. Owens Iii, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102
    • (2006) Int. J. Pharm. , vol.307 , pp. 93-102
    • Owens Iii., D.E.1    Peppas, N.A.2
  • 14
    • 59649097447 scopus 로고    scopus 로고
    • Lipid nanoparticles for parenteral delivery of actives
    • M.D. Joshi, and R.H. Müller Lipid nanoparticles for parenteral delivery of actives Eur. J. Pharm. Biopharm. 71 2009 161 172
    • (2009) Eur. J. Pharm. Biopharm. , vol.71 , pp. 161-172
    • Joshi, M.D.1    Müller, R.H.2
  • 15
    • 84866737577 scopus 로고    scopus 로고
    • Improvement of drug safety by the use of lipid-based nanocarriers
    • S.B. Lim, A. Banerjee, and H. Önyüksel Improvement of drug safety by the use of lipid-based nanocarriers J. Control. Release 163 2012 34 45
    • (2012) J. Control. Release , vol.163 , pp. 34-45
    • Lim, S.B.1    Banerjee, A.2    Önyüksel, H.3
  • 16
    • 84862682458 scopus 로고    scopus 로고
    • Safety assessment of nanomaterials: Implications for nanomedicine
    • A.M. Nyström, and B. Fadeel Safety assessment of nanomaterials: implications for nanomedicine J. Control. Release 161 2012 403 408
    • (2012) J. Control. Release , vol.161 , pp. 403-408
    • Nyström, A.M.1    Fadeel, B.2
  • 17
    • 51049104302 scopus 로고    scopus 로고
    • Pharmacokinetics and biodistribution of nanoparticles
    • S.-D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharma. 5 2008 496 504
    • (2008) Mol. Pharma. , vol.5 , pp. 496-504
    • Li, S.-D.1    Huang, L.2
  • 19
    • 0038032150 scopus 로고    scopus 로고
    • Solid lipid nanoparticles (SLN) for controlled drug delivery-A review of the state of the art
    • R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
    • (2000) Eur. J. Pharm. Biopharm. , vol.50 , pp. 161-177
    • Müller, R.H.1    Mäder, K.2    Gohla, S.3
  • 21
    • 84919337092 scopus 로고    scopus 로고
    • Institute for Laboratory Animal Research eigth ed., National Academies Press (US), Washington (DC)
    • Institute for Laboratory Animal Research, Animals Guide for the Care and Use of Laboratory Animals, eigth ed., National Academies Press (US), Washington (DC), 2011.
    • (2011) Animals Guide for the Care and Use of Laboratory Animals
  • 22
    • 0018127813 scopus 로고
    • Bone marrow in male and female rats
    • D. Dekanić Bone marrow in male and female rats Experientia 34 1978 1313 1314
    • (1978) Experientia , vol.34 , pp. 1313-1314
    • Dekanić, D.1
  • 23
    • 84866737577 scopus 로고    scopus 로고
    • Improvement of drug safety by the use of lipid-based nanocarriers
    • S.B. Lim, A. Banerjee, and H. Önyüksel Improvement of drug safety by the use of lipid-based nanocarriers J. Control. Release 163 2012 34 45
    • (2012) J. Control. Release , vol.163 , pp. 34-45
    • Lim, S.B.1    Banerjee, A.2    Önyüksel, H.3
  • 24
    • 10744230753 scopus 로고    scopus 로고
    • Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles
    • T.M. Göppert, and R.H. Müller Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles J. Drug Target. 11 2003 225 231
    • (2003) J. Drug Target. , vol.11 , pp. 225-231
    • Göppert, T.M.1    Müller, R.H.2
  • 25
    • 84858616151 scopus 로고    scopus 로고
    • Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution
    • S. Dufort, L. Sancey, and J.L. Coll Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution Adv. Drug Deliv. Rev. 64 2012 179 189
    • (2012) Adv. Drug Deliv. Rev. , vol.64 , pp. 179-189
    • Dufort, S.1    Sancey, L.2    Coll, J.L.3
  • 26
    • 77952482569 scopus 로고    scopus 로고
    • Effects of poloxamer 188 on the characteristics of poly(lactide-co- glycolide) nanoparticles
    • J.M. Chae, S.M. Mo, and I.J. Oh Effects of poloxamer 188 on the characteristics of poly(lactide-co-glycolide) nanoparticles J. Nanosci. Nanotechnol. 10 2010 3224 3227
    • (2010) J. Nanosci. Nanotechnol. , vol.10 , pp. 3224-3227
    • Chae, J.M.1    Mo, S.M.2    Oh, I.J.3
  • 27
    • 79954468694 scopus 로고    scopus 로고
    • Pegylation of poly(γ-benzyl-l-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats
    • I. Ozcan, F. Segura-Sánchez, K. Bouchemal, M. Sezak, O. Ozer, T. Güneri, and G. Ponchel Pegylation of poly(γ-benzyl-l-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats Int. J. Nanomedicine 5 2010 1103 1111
    • (2010) Int. J. Nanomedicine , vol.5 , pp. 1103-1111
    • Ozcan, I.1    Segura-Sánchez, F.2    Bouchemal, K.3    Sezak, M.4    Ozer, O.5    Güneri, T.6    Ponchel, G.7
  • 28
    • 0343191443 scopus 로고    scopus 로고
    • 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
    • R. Gref, M. Lück, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R.H. Müller 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf. B: Biointerfaces 18 2000 301 313
    • (2000) Colloids Surf. B: Biointerfaces , vol.18 , pp. 301-313
    • Gref, R.1    Lück, M.2    Quellec, P.3    Marchand, M.4    Dellacherie, E.5    Harnisch, S.6    Blunk, T.7    Müller, R.H.8
  • 29
    • 0029379537 scopus 로고
    • Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
    • G. Storm, S.O. Belliot, T. Daemen, and D.D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 1995 31 48
    • (1995) Adv. Drug Deliv. Rev. , vol.17 , pp. 31-48
    • Storm, G.1    Belliot, S.O.2    Daemen, T.3    Lasic, D.D.4
  • 32
    • 0037269112 scopus 로고    scopus 로고
    • Interactions of VIP, secretin and PACAP(1-38) with phospholipids: A biological paradox revisited
    • A. Krishnadas, H. Önyüksel, and I. Rubinstein Interactions of VIP, secretin and PACAP(1-38) with phospholipids: a biological paradox revisited Curr. Pharm. Des. 9 2003 1005 1012
    • (2003) Curr. Pharm. Des. , vol.9 , pp. 1005-1012
    • Krishnadas, A.1    Önyüksel, H.2    Rubinstein, I.3
  • 33
    • 33746881443 scopus 로고    scopus 로고
    • Human VIP-alpha: A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension
    • H. Önyüksel, S. Séjourné, H. Suzuki, and I. Rubinstein Human VIP-alpha: a long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension Peptides 27 2006 2271 2275
    • (2006) Peptides , vol.27 , pp. 2271-2275
    • Önyüksel, H.1    Séjourné, S.2    Suzuki, H.3    Rubinstein, I.4
  • 34
    • 33646802288 scopus 로고    scopus 로고
    • Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters
    • I. Rubinstein, H. Ikezaki, and H. Önyüksel Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters Int. J. Pharm. 316 2006 144 147
    • (2006) Int. J. Pharm. , vol.316 , pp. 144-147
    • Rubinstein, I.1    Ikezaki, H.2    Önyüksel, H.3
  • 35
    • 84862639203 scopus 로고    scopus 로고
    • Human pancreatic polypeptide in a phospholipid-based micellar formulation
    • A. Banerjee, and H. Önyüksel Human pancreatic polypeptide in a phospholipid-based micellar formulation Pharm. Res. 29 2012 1698 1711
    • (2012) Pharm. Res. , vol.29 , pp. 1698-1711
    • Banerjee, A.1    Önyüksel, H.2
  • 37
    • 84857040855 scopus 로고    scopus 로고
    • Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice
    • D. Delgado, A.R. Gascón, A. del Pozo-Rodríguez, E. Echevarria, A.P. Ruíz de Garibay, J.M. Rodríguez, and M.A. Solinís Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice Int. J. Pharm. 425 2012 35 43
    • (2012) Int. J. Pharm. , vol.425 , pp. 35-43
    • Delgado, D.1    Gascón, A.R.2    Del Pozo-Rodríguez, A.3    Echevarria, E.4    Ruíz De Garibay, A.P.5    Rodríguez, J.M.6    Solinís, M.A.7
  • 38
    • 33646648428 scopus 로고    scopus 로고
    • Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies
    • L. Reddy, R. Sharma, K. Chuttani, A. Mishra, and R. Murthy Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies AAPS J. 6 2004 55 64
    • (2004) AAPS J. , vol.6 , pp. 55-64
    • Reddy, L.1    Sharma, R.2    Chuttani, K.3    Mishra, A.4    Murthy, R.5
  • 39
    • 21744460519 scopus 로고    scopus 로고
    • Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice
    • L. Harivardhan Reddy, R.K. Sharma, K. Chuttani, A.K. Mishra, and R.S.R. Murthy Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice J. Control. Release 105 2005 185 198
    • (2005) J. Control. Release , vol.105 , pp. 185-198
    • Harivardhan Reddy, L.1    Sharma, R.K.2    Chuttani, K.3    Mishra, A.K.4    Murthy, R.S.R.5
  • 41
    • 79959866972 scopus 로고    scopus 로고
    • Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles
    • A.J. Cole, A.E. David, J. Wang, C.J. Galbán, and V.C. Yang Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles Biomaterials 32 2011 6291 6301
    • (2011) Biomaterials , vol.32 , pp. 6291-6301
    • Cole, A.J.1    David, A.E.2    Wang, J.3    Galbán, C.J.4    Yang, V.C.5
  • 43
    • 77953160273 scopus 로고    scopus 로고
    • In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles
    • C. Yan, J. Gu, Y. Guo, and D. Chen In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles Yakugaku Zasshi. 130 2010 801 804
    • (2010) Yakugaku Zasshi. , vol.130 , pp. 801-804
    • Yan, C.1    Gu, J.2    Guo, Y.3    Chen, D.4
  • 45
    • 79952008706 scopus 로고    scopus 로고
    • The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles
    • K. Xiao, Y. Li, J. Luo, J.S. Lee, W. Xiao, A.M. Gonik, R.G. Agarwal, and K.S. Lam The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles Biomaterials 32 2011 3435 3446
    • (2011) Biomaterials , vol.32 , pp. 3435-3446
    • Xiao, K.1    Li, Y.2    Luo, J.3    Lee, J.S.4    Xiao, W.5    Gonik, A.M.6    Agarwal, R.G.7    Lam, K.S.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.